Epstein Secrets

shingtonpost.com/opinions/trumps-pressure-on-the-fda-may-be-risky-for-your- health/2020/08/24/03d113a8-e633-11ea-bc79-834454439a44_story.html> (8/24, Editorial Board, 14.2M) says the use of convalescent plasma therapy so far shows "promising signals from exploratory studies but not full results from a randomized

t. On NBC Nightly News <https://playvideo.bulletinintelligence.corn/ed6acbba7a9f4e498e804748dcd439bf?pubid=fbi> (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are] cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Directo

ays, "the truth is, we can't afford to rush." WPost, NYTimes, WSJoumal Divided On FDA's Decision. On its editorial page, the Washington Post (8/24, Editorial Board, 14.2M) says the use of convalescent plasma therapy so far shows "promising signals from exploratory studies but not full results from a randomized

" Two of the three networks reported Monday night on the FDA's approval of the treatment. On NBC Nightly NewsVi (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are) cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Direct

ays, "the truth is, we can't afford to rush." WPost, NYTimes, WSJoumal Divided On FDA's Decision. On its editorial page, the Washington Post (8/24, Editorial Board, 14.2M) says the use of convalescent plasma therapy so far shows "promising signals from exploratory studies but not full results from a randomized

" Two of the three networks reported Monday night on the FDA's approval of the treatment. On NBC Nightly NewsVi (8/24, story 7, 2:45, Holt, 6.03M), Tom Costello reported that "infectious disease experts [are) cautious and divided about convalescent plasma. Just last week, NIH Director Collins, [NIAID Direct